APO Research
Talk to an analyst

APO RESEARCH · REPORT

High-Purity PLGA Polymers for Long-Acting Injectables

Compare research editions
View pricing & licenses

Selected research

Industry Research

High-Purity PLGA Polymers for Long-Acting Injectables Industry Research Report 2026

13 August 2026129 pages

Choose your research edition.

Industry ResearchHigh-Purity PLGA Polymers for Long-Acting Injectables Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal High-Purity PLGA Polymers for Long-Acting Injectables Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal High-Purity PLGA Polymers for Long-Acting Injectables Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global High-Purity PLGA Polymers for Long-Acting Injectables market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for High-Purity PLGA Polymers for Long-Acting Injectables is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for High-Purity PLGA Polymers for Long-Acting Injectables is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for High-Purity PLGA Polymers for Long-Acting Injectables is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of High-Purity PLGA Polymers for Long-Acting Injectables include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global High-Purity PLGA Polymers for Long-Acting Injectables market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to High-Purity PLGA Polymers for Long-Acting Injectables.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

High-Purity PLGA Polymers for Long-Acting Injectables Market by Company

Evonik Industries AG

Corbion N.V.

Ashland Inc.

SEQENS

Mitsui Chemicals, Inc.

Nanjing Well Pharmaceutical Group Co., Ltd.

Guangzhou DiQi Pharmaceuticals Co., Ltd.

Nomisma Healthcare Pvt. Ltd.

Zhejiang Langhua Pharmaceutical Co., Ltd.

Hunan Er-Kang Pharmaceutical Co., Ltd.

Shanghai Libaimei Biotechnology Co., Ltd.

Zhejiang Bangyao Biomaterials Co., Ltd.

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Type

PLGA 50:50

PLGA 75:25

PLGA 85:15

Other Ratios and Customized PLGA

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Application

Sustained-release Microspheres

In-situ Forming Depot Systems

Biodegradable Drug-eluting Implants

Nanoparticle Drug Delivery Systems

Other Parenteral Controlled-release Applications

High-Purity PLGA Polymers for Long-Acting Injectables Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High-Purity PLGA Polymers for Long-Acting Injectables market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High-Purity PLGA Polymers for Long-Acting Injectables and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High-Purity PLGA Polymers for Long-Acting Injectables.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of High-Purity PLGA Polymers for Long-Acting Injectables manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of High-Purity PLGA Polymers for Long-Acting Injectables by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of High-Purity PLGA Polymers for Long-Acting Injectables in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Manufacturers (t) & (2021-2026) Table 6. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Manufacturers Table 7. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Manufacturers (2021-2026) Table 9. Global High-Purity PLGA Polymers for Long-Acting Injectables Average Price (USD/t) of Manufacturers (2021-2026) Table 10. Global High-Purity PLGA Polymers for Long-Acting Injectables Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global High-Purity PLGA Polymers for Long-Acting Injectables Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Product Type & Application Table 13. Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global High-Purity PLGA Polymers for Long-Acting Injectables by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Evonik Industries AG Company Information Table 18. Evonik Industries AG Business Overview Table 19. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 20. Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 21. Evonik Industries AG Recent Development Table 22. Corbion N.V. Company Information Table 23. Corbion N.V. Business Overview Table 24. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 25. Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 26. Corbion N.V. Recent Development Table 27. Ashland Inc. Company Information Table 28. Ashland Inc. Business Overview Table 29. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 30. Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 31. Ashland Inc. Recent Development Table 32. SEQENS Company Information Table 33. SEQENS Business Overview Table 34. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 35. SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 36. SEQENS Recent Development Table 37. Mitsui Chemicals, Inc. Company Information Table 38. Mitsui Chemicals, Inc. Business Overview Table 39. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 40. Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 41. Mitsui Chemicals, Inc. Recent Development Table 42. Nanjing Well Pharmaceutical Group Co., Ltd. Company Information Table 43. Nanjing Well Pharmaceutical Group Co., Ltd. Business Overview Table 44. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 46. Nanjing Well Pharmaceutical Group Co., Ltd. Recent Development Table 47. Guangzhou DiQi Pharmaceuticals Co., Ltd. Company Information Table 48. Guangzhou DiQi Pharmaceuticals Co., Ltd. Business Overview Table 49. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 50. Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 51. Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Development Table 52. Nomisma Healthcare Pvt. Ltd. Company Information Table 53. Nomisma Healthcare Pvt. Ltd. Business Overview Table 54. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 55. Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 56. Nomisma Healthcare Pvt. Ltd. Recent Development Table 57. Zhejiang Langhua Pharmaceutical Co., Ltd. Company Information Table 58. Zhejiang Langhua Pharmaceutical Co., Ltd. Business Overview Table 59. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 60. Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 61. Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Development Table 62. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Information Table 63. Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview Table 64. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 65. Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 66. Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Development Table 67. Shanghai Libaimei Biotechnology Co., Ltd. Company Information Table 68. Shanghai Libaimei Biotechnology Co., Ltd. Business Overview Table 69. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 70. Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 71. Shanghai Libaimei Biotechnology Co., Ltd. Recent Development Table 72. Zhejiang Bangyao Biomaterials Co., Ltd. Company Information Table 73. Zhejiang Bangyao Biomaterials Co., Ltd. Business Overview Table 74. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 75. Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Product Portfolio Table 76. Zhejiang Bangyao Biomaterials Co., Ltd. Recent Development Table 77. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison by Region: 2021 VS 2025 VS 2032 (t) Table 78. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region (2021-2026) & (t) Table 79. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region (2021-2026) Table 80. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Forecast by Region (2027-2032) & (t) Table 81. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share Forecast by Region (2027-2032) Table 82. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region (2021-2026) & (US$ Million) Table 84. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region (2021-2026) Table 85. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Forecast by Region (2027-2032) & (US$ Million) Table 86. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Average Price (USD/t) by Region (2021-2026) Table 87. Global High-Purity PLGA Polymers for Long-Acting Injectables Market Average Price (USD/t) by Region (2027-2032) Table 88. Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison by Region: 2021 VS 2025 VS 2032 (t) Table 89. Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region (2021-2026) & (t) Table 90. Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Region (2021-2026) Table 91. Global High-Purity PLGA Polymers for Long-Acting Injectables Forecasted Consumption by Region (2027-2032) & (t) Table 92. Global High-Purity PLGA Polymers for Long-Acting Injectables Forecasted Consumption Market Share by Region (2027-2032) Table 93. North America High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 94. North America High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2026) & (t) Table 95. North America High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2027-2032) & (t) Table 96. Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 97. Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2026) & (t) Table 98. Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2027-2032) & (t) Table 99. Asia Pacific High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 100. Asia Pacific High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2026) & (t) Table 101. Asia Pacific High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2027-2032) & (t) Table 102. South America, Middle East & Africa High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 103. South America, Middle East & Africa High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2026) & (t) Table 104. South America, Middle East & Africa High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2027-2032) & (t) Table 105. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2021-2026) & (t) Table 106. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2027-2032) & (t) Table 107. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Type (2021-2026) Table 108. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Type (2027-2032) Table 109. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2021-2026) & (US$ Million) Table 110. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2027-2032) & (US$ Million) Table 111. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type (2021-2026) Table 112. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type (2027-2032) Table 113. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2026) & (USD/t) Table 114. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2027-2032) & (USD/t) Table 115. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2021-2026) & (t) Table 116. Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2027-2032) & (t) Table 117. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Application (2021-2026) Table 118. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Application (2027-2032) Table 119. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2021-2026) & (US$ Million) Table 120. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2027-2032) & (US$ Million) Table 121. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application (2021-2026) Table 122. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application (2027-2032) Table 123. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2026) & (USD/t) Table 124. Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2027-2032) & (USD/t) Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. High-Purity PLGA Polymers for Long-Acting Injectables Distributors List Table 128. High-Purity PLGA Polymers for Long-Acting Injectables Customers List Table 129. High-Purity PLGA Polymers for Long-Acting Injectables Industry Trends Table 130. High-Purity PLGA Polymers for Long-Acting Injectables Industry Drivers Table 131. High-Purity PLGA Polymers for Long-Acting Injectables Industry Restraints Table 132. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. High-Purity PLGA Polymers for Long-Acting Injectables Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. PLGA 50:50 Product Image Figure 7. PLGA 75:25 Product Image Figure 8. PLGA 85:15 Product Image Figure 9. Other Ratios and Customized PLGA Product Image Figure 10. Sustained-release Microspheres Product Image Figure 11. In-situ Forming Depot Systems Product Image Figure 12. Biodegradable Drug-eluting Implants Product Image Figure 13. Nanoparticle Drug Delivery Systems Product Image Figure 14. Other Parenteral Controlled-release Applications Product Image Figure 15. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value (2021-2032) & (US$ Million) Figure 17. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity (2021-2032) & (t) Figure 18. Global High-Purity PLGA Polymers for Long-Acting Injectables Production (2021-2032) & (t) Figure 19. Global High-Purity PLGA Polymers for Long-Acting Injectables Average Price (USD/t) & (2021-2032) Figure 20. Global High-Purity PLGA Polymers for Long-Acting Injectables Key Manufacturers, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 High-Purity PLGA Polymers for Long-Acting Injectables Players Market Share by Production Value in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Comparison by Region: 2021 VS 2025 VS 2032 (t) Figure 24. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 25. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America High-Purity PLGA Polymers for Long-Acting Injectables Production Value (US$ Million) Growth Rate (2021-2032) Figure 28. Europe High-Purity PLGA Polymers for Long-Acting Injectables Production Value (US$ Million) Growth Rate (2021-2032) Figure 29. China High-Purity PLGA Polymers for Long-Acting Injectables Production Value (US$ Million) Growth Rate (2021-2032) Figure 30. Japan High-Purity PLGA Polymers for Long-Acting Injectables Production Value (US$ Million) Growth Rate (2021-2032) Figure 31. Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption Comparison by Region: 2021 VS 2025 VS 2032 (t) Figure 32. Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 34. North America High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Country (2021-2032) Figure 35. United States High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 36. United States High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 37. Canada High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 38. Mexico High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 39. Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 40. Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Country (2021-2032) Figure 41. Germany High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 42. France High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 43. U.K. High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 44. Italy High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 45. Russia High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 46. Spain High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 47. Netherlands High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 48. Switzerland High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 49. Sweden High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 50. Poland High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 51. Asia Pacific High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 52. Asia Pacific High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Country (2021-2032) Figure 53. China High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 54. Japan High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 55. South Korea High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 56. India High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 57. Australia High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 58. Taiwan High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 59. Southeast Asia High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 60. South America, Middle East & Africa High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 61. South America, Middle East & Africa High-Purity PLGA Polymers for Long-Acting Injectables Consumption Market Share by Country (2021-2032) Figure 62. Brazil High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 63. Argentina High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 64. Chile High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 65. Turkey High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 66. GCC Countries High-Purity PLGA Polymers for Long-Acting Injectables Consumption and Growth Rate (2021-2032) & (t) Figure 67. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Type (2021-2032) Figure 68. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type (2021-2032) Figure 69. Global High-Purity PLGA Polymers for Long-Acting Injectables Price (USD/t) by Type (2021-2032) Figure 70. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Application (2021-2032) Figure 71. Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application (2021-2032) Figure 72. Global High-Purity PLGA Polymers for Long-Acting Injectables Price (USD/t) by Application (2021-2032) Figure 73. High-Purity PLGA Polymers for Long-Acting Injectables Value Chain Figure 74. High-Purity PLGA Polymers for Long-Acting Injectables Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. High-Purity PLGA Polymers for Long-Acting Injectables Industry Opportunities and Challenges

Scope & coverage.

Types
  • PLGA 50:50
  • PLGA 75:25
  • PLGA 85:15
  • Other Ratios and Customized PLGA
Applications
  • Sustained-release Microspheres
  • In-situ Forming Depot Systems
  • Biodegradable Drug-eluting Implants
  • Nanoparticle Drug Delivery Systems
  • Other Parenteral Controlled-release Applications
Companies covered
  • Evonik Industries AG
  • Corbion N.V.
  • Ashland Inc.
  • SEQENS
  • Mitsui Chemicals, Inc.
  • Nanjing Well Pharmaceutical Group Co., Ltd.
  • Guangzhou DiQi Pharmaceuticals Co., Ltd.
  • Nomisma Healthcare Pvt. Ltd.
  • Zhejiang Langhua Pharmaceutical Co., Ltd.
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Shanghai Libaimei Biotechnology Co., Ltd.
  • Zhejiang Bangyao Biomaterials Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 High-Purity PLGA Polymers for Long-Acting Injectables by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 PLGA 50:50
  5. 2.2.3 PLGA 75:25
  6. 2.2.4 PLGA 85:15
  7. 2.2.5 Other Ratios and Customized PLGA
  8. 2.3 High-Purity PLGA Polymers for Long-Acting Injectables by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  10. 2.3.2 Sustained-release Microspheres
  11. 2.3.3 In-situ Forming Depot Systems
  12. 2.3.4 Biodegradable Drug-eluting Implants
  13. 2.3.5 Nanoparticle Drug Delivery Systems
  14. 2.3.6 Other Parenteral Controlled-release Applications
  15. 2.4 Global Market Growth Prospects
  16. 2.4.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Estimates and Forecasts (2021-2032)
  17. 2.4.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity Estimates and Forecasts (2021-2032)
  18. 2.4.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Estimates and Forecasts (2021-2032)
  19. 2.4.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Manufacturers (2021-2026)
  2. 3.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Manufacturers (2021-2026)
  3. 3.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Average Price by Manufacturers (2021-2026)
  4. 3.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global High-Purity PLGA Polymers for Long-Acting Injectables Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers, Product Type & Application
  7. 3.7 Global High-Purity PLGA Polymers for Long-Acting Injectables Manufacturers Established Date
  8. 3.8 Global High-Purity PLGA Polymers for Long-Acting Injectables Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Evonik Industries AG
  2. 4.1.1 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  3. 4.1.2 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  4. 4.1.3 Evonik Industries AG High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Evonik Industries AG Product Portfolio
  6. 4.1.5 Evonik Industries AG Recent Developments
  7. 4.2 Corbion N.V.
  8. 4.2.1 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  9. 4.2.2 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  10. 4.2.3 Corbion N.V. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Corbion N.V. Product Portfolio
  12. 4.2.5 Corbion N.V. Recent Developments
  13. 4.3 Ashland Inc.
  14. 4.3.1 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  15. 4.3.2 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  16. 4.3.3 Ashland Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Ashland Inc. Product Portfolio
  18. 4.3.5 Ashland Inc. Recent Developments
  19. 4.4 SEQENS
  20. 4.4.1 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  21. 4.4.2 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  22. 4.4.3 SEQENS High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 SEQENS Product Portfolio
  24. 4.4.5 SEQENS Recent Developments
  25. 4.5 Mitsui Chemicals, Inc.
  26. 4.5.1 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  27. 4.5.2 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  28. 4.5.3 Mitsui Chemicals, Inc. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Mitsui Chemicals, Inc. Product Portfolio
  30. 4.5.5 Mitsui Chemicals, Inc. Recent Developments
  31. 4.6 Nanjing Well Pharmaceutical Group Co., Ltd.
  32. 4.6.1 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  33. 4.6.2 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  34. 4.6.3 Nanjing Well Pharmaceutical Group Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Nanjing Well Pharmaceutical Group Co., Ltd. Product Portfolio
  36. 4.6.5 Nanjing Well Pharmaceutical Group Co., Ltd. Recent Developments
  37. 4.7 Guangzhou DiQi Pharmaceuticals Co., Ltd.
  38. 4.7.1 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  39. 4.7.2 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  40. 4.7.3 Guangzhou DiQi Pharmaceuticals Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Guangzhou DiQi Pharmaceuticals Co., Ltd. Product Portfolio
  42. 4.7.5 Guangzhou DiQi Pharmaceuticals Co., Ltd. Recent Developments
  43. 4.8 Nomisma Healthcare Pvt. Ltd.
  44. 4.8.1 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  45. 4.8.2 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  46. 4.8.3 Nomisma Healthcare Pvt. Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Nomisma Healthcare Pvt. Ltd. Product Portfolio
  48. 4.8.5 Nomisma Healthcare Pvt. Ltd. Recent Developments
  49. 4.9 Zhejiang Langhua Pharmaceutical Co., Ltd.
  50. 4.9.1 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  51. 4.9.2 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  52. 4.9.3 Zhejiang Langhua Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Zhejiang Langhua Pharmaceutical Co., Ltd. Product Portfolio
  54. 4.9.5 Zhejiang Langhua Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Hunan Er-Kang Pharmaceutical Co., Ltd.
  56. 4.10.1 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  57. 4.10.2 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  58. 4.10.3 Hunan Er-Kang Pharmaceutical Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Hunan Er-Kang Pharmaceutical Co., Ltd. Product Portfolio
  60. 4.10.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Shanghai Libaimei Biotechnology Co., Ltd.
  62. 4.11.1 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  63. 4.11.2 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  64. 4.11.3 Shanghai Libaimei Biotechnology Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Shanghai Libaimei Biotechnology Co., Ltd. Product Portfolio
  66. 4.11.5 Shanghai Libaimei Biotechnology Co., Ltd. Recent Developments
  67. 4.12 Zhejiang Bangyao Biomaterials Co., Ltd.
  68. 4.12.1 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Company Information
  69. 4.12.2 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Business Overview
  70. 4.12.3 Zhejiang Bangyao Biomaterials Co., Ltd. High-Purity PLGA Polymers for Long-Acting Injectables Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Zhejiang Bangyao Biomaterials Co., Ltd. Product Portfolio
  72. 4.12.5 Zhejiang Bangyao Biomaterials Co., Ltd. Recent Developments
5 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region
  1. 5.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region: 2021-2032
  3. 5.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Region: 2021-2026
  4. 5.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Forecast by Region (2027-2032)
  5. 5.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region: 2021-2032
  7. 5.4.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Region: 2021-2026
  8. 5.4.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Forecast by Region (2027-2032)
  9. 5.5 Global High-Purity PLGA Polymers for Long-Acting Injectables Market Price Analysis by Region (2021-2026)
  10. 5.6 Global High-Purity PLGA Polymers for Long-Acting Injectables Production and Value, YOY Growth
  11. 5.6.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China High-Purity PLGA Polymers for Long-Acting Injectables Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan High-Purity PLGA Polymers for Long-Acting Injectables Production Value Estimates and Forecasts (2021-2032)
6 Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region
  1. 6.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region (2021-2032)
  3. 6.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Region: 2021-2026
  4. 6.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa High-Purity PLGA Polymers for Long-Acting Injectables Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa High-Purity PLGA Polymers for Long-Acting Injectables Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2021-2032)
  2. 7.1.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Type (2021-2032) & (t)
  3. 7.1.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Type (2021-2032)
  4. 7.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2021-2032)
  5. 7.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Type (2021-2032)
  7. 7.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2021-2032)
  2. 8.1.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production by Application (2021-2032) & (t)
  3. 8.1.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Market Share by Application (2021-2032)
  4. 8.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2021-2032)
  5. 8.2.1 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global High-Purity PLGA Polymers for Long-Acting Injectables Production Value Market Share by Application (2021-2032)
  7. 8.3 Global High-Purity PLGA Polymers for Long-Acting Injectables Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 High-Purity PLGA Polymers for Long-Acting Injectables Value Chain Analysis
  2. 9.1.1 High-Purity PLGA Polymers for Long-Acting Injectables Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 High-Purity PLGA Polymers for Long-Acting Injectables Production Mode & Process
  5. 9.2 High-Purity PLGA Polymers for Long-Acting Injectables Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 High-Purity PLGA Polymers for Long-Acting Injectables Distributors
  8. 9.2.3 High-Purity PLGA Polymers for Long-Acting Injectables Customers
10 Global High-Purity PLGA Polymers for Long-Acting Injectables Analyzing Market Dynamics
  1. 10.1 High-Purity PLGA Polymers for Long-Acting Injectables Industry Trends
  2. 10.2 High-Purity PLGA Polymers for Long-Acting Injectables Industry Drivers
  3. 10.3 High-Purity PLGA Polymers for Long-Acting Injectables Industry Opportunities and Challenges
  4. 10.4 High-Purity PLGA Polymers for Long-Acting Injectables Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst